Nagoya, Japan

Junji Takada

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junji Takada. Retrieved from https://idiyas.com/inventor/junji-takada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Junji Takada: Innovator in Pyridylpyrrole Compounds

Introduction

Junji Takada is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as interleukin and TNF antagonists. His work is crucial in advancing treatments for various inflammatory diseases.

Latest Patents

Junji Takada holds 1 patent for his invention of pyridylpyrrole compounds. This patent focuses on the utility of these compounds in medical applications, showcasing his innovative approach to addressing complex health issues.

Career Highlights

Currently, Junji Takada is employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Throughout his career, Junji has worked alongside talented colleagues, including Akiyoshi Kawai and Makoto Kawai. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their shared field of expertise.

Conclusion

Junji Takada's contributions to the development of pyridylpyrrole compounds highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for new therapeutic options, demonstrating the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…